Vaccine Development Insights
Erin and Elena discuss the development of a recombinant protein-based vaccine targeting the spike protein of SARS-CoV-2. Elena highlights the importance of using proven technology to ensure affordability and accessibility, especially for low and middle-income countries. The conversation delves into the specifics of the receptor binding domain and the potential for cross-protection based on previous research on the SARS virus.In this clip
From this podcast
This Podcast Will Kill You
COVID-19 Chapter 5: Vaccines
Related Questions